TEN Stock Overview

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. More details

TEN fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	2/6
Financial Health	5/6
Dividends	5/6

Rewards

Trading at 16.5% below our estimate of its fair value

Earnings are forecast to grow 16.37% per year

Pays a reliable dividend of 1.81%

Risk Analysis

Shares are highly illiquid

Profit margins (7.2%) are lower than last year (12.3%)

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Tecan Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tecan Group
Historical stock prices
Current Share Price	CHF 180.10
52 Week High	CHF 188.60
52 Week Low	CHF 168.60
Beta	0.97
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	400.97%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	TEN	DE Life Sciences	DE Market
7D	-2.9%	-2.6%	-0.9%
1Y	n/a	-5.8%	14.1%

Return vs Industry: Insufficient data to determine how TEN performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how TEN performed against the German Market.

Price Volatility

Is TEN's price volatile compared to industry and market?
TEN volatility
TEN Average Weekly Movement	n/a
Life Sciences Industry Average Movement	7.1%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: TEN's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine TEN's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1980	3,208	Achim von Leoprechting	www.tecan.com

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution.

Tecan Group AG Fundamentals Summary

How do Tecan Group's earnings and revenue compare to its market cap?
TEN fundamental statistics
Market cap	€2.26b
Earnings (TTM)	€72.57m
Revenue (TTM)	€1.00b

31.1x

P/E Ratio

2.3x

P/S Ratio

Is TEN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TEN income statement (TTM)
Revenue	CHF 934.28m
Cost of Revenue	CHF 613.68m
Gross Profit	CHF 320.60m
Other Expenses	CHF 252.93m
Earnings	CHF 67.66m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Jun 12, 2025

Earnings per share (EPS)	5.32
Gross Margin	34.32%
Net Profit Margin	7.24%
Debt/Equity Ratio	17.4%

How did TEN perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

57%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/25 12:06
End of Day Share Price	2025/05/23 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tecan Group AG is covered by 23 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Leonildo Delgado	Baader Helvea Equity Research
Markus Mayer	Baader Helvea Equity Research
Volker Bosse	Baader Helvea Equity Research